Page 348 - Read Online

Page 26 of 31 Paul J Cancer Metastasis Treat 2020;6:29 I http://dx.doi.org/10.20517/2394-4722.2020.63

34. Caon I, Bartolini B, Parnigoni A, Carava E, Moretto P, et al. Revisiting the hallmarks of cancer: the role of hyaluronan. Semin Cancer
Biol 2020;62:9-19.
35. Amson R, Karp JE, Telerman A. Lessons from tumor reversion for cancer treatment. Curr Opin Oncol 2013;25:59-65.
36. Sun Y, Ma L. The emerging molecular machinery and therapeutic targets of metastasis. Trends Pharmacol Sci 2015;36:349-59.
37. Scheel C, Onder T, Karnoub A, Weinberg RA. Adaptation versus selection: the origins of metastatic behavior. Cancer Res 2007;67:11476-
9; discussion 9-80.
38. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009;285:116-26.
39. Nath S, Ghatak D, Das P, Roychoudhury S. Transcriptional control of mitosis: deregulation and cancer. Front Endocrinol (Lausanne)
2015;6:60.
40. Chiaretti S, de Curtis I. Role of liprins in the regulation of tumor cell motility and invasion. Curr Cancer Drug Targets 2016;16:238-48.
41. Saini P, Courtneidge SA. Tks adaptor proteins at a glance. J Cell Sci 2018;131.
42. Anfossi S, Fu X, Nagvekar R, Calin GA. MicroRNAs, regulatory messengers inside and outside cancer cells. Adv Exp Med Biol
2018;1056:87-108.
43. Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi C, et al. Extracellular vesicle and particle biomarkers define multiple human cancers.
Cell 2020;182:1-18.
44. Wortzel I, Dror S, Kenific CM, Lyden D. Exosome-mediated metastasis: communication from a distance. Dev Cell 2019;49:347-60.
45. Schwarzenbach H, Gahan PB. MicroRNA shuttle from cell-to-cell by exosomes and its impact in cancer. Noncoding RNA 2019;5.
46. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, et al. Tumour exosome integrins determine organotropic metastasis.
Nature 2015;527:329-35.
47. Rodrigues G, Hoshino A, Kenific CM, Matei IR, Steiner L, et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in
brain metastasis. Nat Cell Biol 2019;21:1403-12.
48. Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.
Science 2015;347:78-81.
49. Lau EY, Ho NP, Lee TK. Cancer stem cells and their microenvironment: biology and therapeutic implications. Stem Cells Int
2017;2017:3714190.
50. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour
progression. Nat Rev Cancer 2005;5:744-9.
51. Ganesh K, Basnet H, Kaygusuz Y, Laughney AM, He L, et al. L1CAM defines the regenerative origin of metastasis-initiating cells in
colorectal cancer. Nature Cancer 2020:20-45.
52. Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg
2014;260:416-21; discussion 21-2.
53. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
54. Guizard AN, Dejardin OJ, Launay LC, Bara S, Lapotre-Ledoux BM, et al. Diagnosis and management of head and neck cancers in a
high-incidence area in France: a population-based study. Medicine (Baltimore) 2017;96:e7285.
55. Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. Epidemiology of thyroid cancer: a review of the national cancer database,
2000-2013. Cureus 2019;11:e4127.
56. Welch DR, Hurst DR. Defining the Hallmarks of Metastasis. Cancer Res 2019;79:3011-27.
57. Flanigan RC, Yonover PM. The role of radical nephrectomy in metastatic renal cell carcinoma. Semin Urol Oncol 2001;19:98-102.
58. O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell
1997;88:277-85.
59. Kisker O, Onizuka S, Banyard J, Komiyama T, Becker CM, et al. Generation of multiple angiogenesis inhibitors by human pancreatic
cancer. Cancer Res 2001;61:7298-304.
60. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature 2005;438:820-7.
61. Mareel M, Oliveira MJ, Madani I. Cancer invasion and metastasis: interacting ecosystems. Virchows Arch 2009;454:599-622.
62. Kano Y, Ishii H, Konno M, Yamasaki M, Miyata H, et al. Cells of origin of squamous epithelium, dysplasia and cancer in the head and
neck region after bone marrow transplantation. Int J Oncol 2014;44:443-50.
63. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, et al. Gastric cancer originating from bone marrow-derived cells. Science
2004;306:1568-71.
64. Guest I, Ilic Z, Ma J, Grant D, Glinsky G, et al. Direct and indirect contribution of bone marrow-derived cells to cancer. Int J Cancer
2010;126:2308-18.
65. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 2006;66:11089-93.
66. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to
stimulate metastasis. Nature 2009;457:102-6.
67. Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis 2012;29:381-95.
68. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the
liver. Nat Cell Biol 2015;17:816-26.
69. Liu Y, Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell 2016;30:668-81.
70. Norton JD, Deed RW, Craggs G, Sablitzky F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 1998;8:58-65.
71. Guo L, Guo N. Exosomes: potent regulators of tumor malignancy and potential bio-tools in clinical application. Crit Rev Oncol Hematol